These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1528 related articles for article (PubMed ID: 28130223)

  • 1. HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells.
    Zhu S; Zhang Q; Sun X; Zeh HJ; Lotze MT; Kang R; Tang D
    Cancer Res; 2017 Apr; 77(8):2064-2077. PubMed ID: 28130223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
    Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
    J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EP300 promotes ferroptosis via HSPA5 acetylation in pancreatic cancer.
    Wang Y; Liu Y; Wang C; Kang R; Tang D; Liu J
    Sci Rep; 2023 Sep; 13(1):15004. PubMed ID: 37696842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of acupotomy on chondrocyte ferroptosis in rabbits with knee osteoarthritis based on HSPA5/GPX4 signaling pathway].
    Meng D; Lu M; Wu S; Luan G; Ding S; Zhao H; Zhang F; Yang Y
    Zhongguo Zhen Jiu; 2024 May; 44(5):555-64. PubMed ID: 38764106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis.
    Mao X; Xu J; Xiao M; Liang C; Hua J; Liu J; Wang W; Yu X; Meng Q; Shi S
    Redox Biol; 2024 Jul; 73():103200. PubMed ID: 38781729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer.
    Yang J; Xu J; Zhang B; Tan Z; Meng Q; Hua J; Liu J; Wang W; Shi S; Yu X; Liang C
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma.
    Shang M; Weng L; Xu G; Wu S; Liu B; Yin X; Mao A; Zou X; Wang Z
    J Cell Physiol; 2021 Oct; 236(10):6868-6883. PubMed ID: 33629745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review.
    Garcia-Carbonero N; Li W; Cabeza-Morales M; Martinez-Useros J; Garcia-Foncillas J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134550
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Tadros S; Shukla SK; King RJ; Gunda V; Vernucci E; Abrego J; Chaika NV; Yu F; Lazenby AJ; Berim L; Grem J; Sasson AR; Singh PK
    Cancer Res; 2017 Oct; 77(20):5503-5517. PubMed ID: 28811332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma.
    Gifford JB; Huang W; Zeleniak AE; Hindoyan A; Wu H; Donahue TR; Hill R
    Mol Cancer Ther; 2016 May; 15(5):1043-52. PubMed ID: 26939701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer.
    de Laat V; Topal H; Spotbeen X; Talebi A; Dehairs J; Idkowiak J; Vanderhoydonc F; Ostyn T; Zhao P; Jacquemyn M; Wölk M; Sablina A; Augustyns K; Vanden Berghe T; Roskams T; Daelemans D; Fedorova M; Topal B; Swinnen JV
    Nat Commun; 2024 Oct; 15(1):8540. PubMed ID: 39358362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
    Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
    PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
    Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
    Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
    Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
    Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA-binding protein SND1 promotes the degradation of GPX4 by destabilizing the HSPA5 mRNA and suppressing HSPA5 expression, promoting ferroptosis in osteoarthritis chondrocytes.
    Lv M; Cai Y; Hou W; Peng K; Xu K; Lu C; Yu W; Zhang W; Liu L
    Inflamm Res; 2022 Apr; 71(4):461-472. PubMed ID: 35320827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells.
    Clarke WR; Amundadottir L; James MA
    Int J Cancer; 2019 Mar; 144(6):1367-1378. PubMed ID: 30468251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
    Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K
    Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.
    Awasthi N; Zhang C; Hinz S; Schwarz MA; Schwarz RE
    J Exp Clin Cancer Res; 2013 Mar; 32(1):12. PubMed ID: 23497499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
    Hesler RA; Huang JJ; Starr MD; Treboschi VM; Bernanke AG; Nixon AB; McCall SJ; White RR; Blobe GC
    Carcinogenesis; 2016 Nov; 37(11):1041-1051. PubMed ID: 27604902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.